0.4304
23-May-25 13:45:00
15 minutes delayed
Stocks
-0.0045
-1.03%
Today's range
0.3901 - 0.4412
ISIN
N/A
Source
NASDAQ
Tenaya Therapeutics Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for TN-301, an HDAC6 Inhibitor for Heart Failure with Preserved Ejection Fraction
06 Sep 2022 05:00:02 By Nasdaq GlobeNewswire
Tenaya Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
10 Aug 2022 13:01:00 By Nasdaq GlobeNewswire
Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure
06 Jul 2022 11:00:00 By Nasdaq GlobeNewswire